查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2041927

基因表現分析市場預測至2034年－按產品、技術、應用、最終用戶和地區分類的全球分析

Gene Expression Analysis Market Forecasts to 2034 - Global Analysis By Product (DNA Chips, Kits & Reagents, Services and Other Products), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球基因表現分析市場規模將達到 67 億美元，並在預測期內以 10.8% 的複合年成長率成長，到 2034 年將達到 151 億美元。

基因表現分析是指研究基因轉錄成RNA並翻譯成蛋白質及其編碼的功能產物的過程。這包括在特定條件下測量特定細胞、組織或生物體中的基因活性。此分析有助於深入了解各種生物過程（例如發育、分化、對刺激的反應和疾病）的分子機制。透過檢測基因表現模式，研究人員可以辨識特定路徑中的關鍵基因，闡明基因的調控方式，並深入了解疾病的分子基礎。

根據印度工商聯合會 (FICCI) 2016 年進行的一項調查，印度生物技術產業面臨嚴重的人才短缺，約 80% 的科學家缺乏博士和博士後研究人員，20% 缺乏碩士學位持有者，18% 缺乏生產者。

個人化醫療的普及

隨著基於個人基因譜最佳化治療方案的重要性日益凸顯，個人化醫療市場正蓬勃發展。這一趨勢的驅動力源自於基因組研究和技術的進步，這些進步使得基因表現模式的分析更加精準。隨著醫療服務提供者對個人化治療方案價值的認知不斷加深，預計市場將進一步擴張，為客製化治療方法和診斷提供創新解決方案。

熟練專業人員短缺

精通基因表現數據解讀和分析的專業人才需求遠遠超過現有勞動力供應。這種人才短缺對充分發揮基因組學在疾病理解和標靶治療開發方面的潛力構成重大挑戰。透過教育和培訓計劃彌合這一差距，對於推動該領域發展、釋放基因表現分析在醫療保健和生命科學領域的變革潛力至關重要。市場面臨專業人才的嚴重短缺，阻礙了基因組研究、開發和診斷的進展。

科技的快速發展

高通量定序、單細胞分析和生物資訊學的創新使得基因表現分析達到了前所未有的準確性和效率水平。基因表現分析技術的持續發展蘊藏著巨大的潛力，有望推動精準醫療的進步，並徹底改變我們對基因調控的理解。市場上正湧現出快速的技術進步，徹底革新著我們對細胞功能的認知。

設備高成本

基因表現分析所需的先進技術和專用設備導致價格高昂。這種經濟壁壘可能會阻礙小規模實驗室和研究機構充分進行全面的基因表現研究，進而影響該領域科學進步的整體性和發展進程。解決成本問題對於促進基因表現分析研究的更廣泛參與和創新至關重要。高成本正在阻礙市場成長。

新冠疫情的影響：

新冠疫情對市場產生了重大影響。人們對闡明病毒分子機制的興趣日益濃厚，推動了對基因表現分析工具的需求。然而，供應鏈中斷、實驗室關閉以及研究經費削減都帶來了挑戰。市場需求經歷了激增和下降，研究重點也轉向了感染疾病研究。對於該行業的公司而言，適應遠端辦公和數位化解決方案至關重要，這有助於它們應對不確定性並保持發展勢頭。

在預測期內，聚合酵素鏈鎖反應（PCR）細分市場預計將是最大的。

在預測期內，聚合酵素鏈鎖反應(PCR) 細分市場預計將佔據最大佔有率。 PCR 可以擴增特定的 DNA 序列，從而實現高靈敏度和高精度的基因表現分析。對個人化醫療日益成長的需求以及基因組學的進步正在推動市場擴張。領先企業正在投資創新 PCR 技術並強化產品系列。在 PCR 技術於診斷、治療和研究領域應用不斷擴展的推動下，預計該市場將持續成長。

預計在預測期內，藥物發現和開發領域將呈現最高的複合年成長率。

預計在預測期內，藥物發現與開發領域將呈現最高的複合年成長率。研究人員正利用最尖端科技分析基因表現模式，並識別潛在的藥物標靶和生物標記。這種先進的方法加深了我們對疾病機制的理解，並加速了創新治療方法的發展。隨著基因組學和生物資訊學的不斷進步，該市場在塑造精準醫療和個人化治療策略的未來方面仍然至關重要。

市佔率最大的地區：

預計北美將在預測期內佔據最大的市場佔有率。該地區對基因表現分析工具（包括微陣列和次世代定序平台）的需求強勁。推動市場成長的關鍵因素包括基因組學研究活動的活性化、慢性病盛行率的上升以及有利的法規環境。研究機構與產業相關人員之間的合作進一步推動了基因表現分析領域的創新，鞏固了市場的活力。

複合年成長率最高的地區：

亞太地區預計將在預測期內保持最高的複合年成長率，這主要得益於學術機構和生物技術公司之間的合作。該地區的領導企業正積極開發基因表現分析的創新解決方案，從而創造出充滿活力且競爭激烈的市場環境。隨著該地區逐漸成為基因組學和分子生物學研究的重要中心，預計市場成長趨勢將持續下去。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球基因表現分析市場：依產品分類

  • DNA晶片
  • 試劑盒和試劑
  • 服務
  • 其他產品

第6章 全球基因表現分析市場：依技術分類

  • 次世代定序（NGS）
  • 聚合酵素鏈鎖反應（PCR）
  • 微陣列
  • 其他技術

第7章 全球基因表現分析市場：依應用領域分類

  • 生物技術與微生物學
  • 臨床診斷
  • 藥物發現與開發
  • 其他用途

第8章 全球基因表現分析市場：依最終用戶分類

  • 學術研究機構
  • 製藥和生物技術公司
  • 其他最終用戶

第9章 全球基因表現分析市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第10章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章：公司簡介

  • Agilent Technologies
  • GE Healthcare
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Luminex Corp.
  • Quest Diagnostics, Inc.
  • PerkinElmer, Inc.
  • Takara Bio, Inc.
  • Catalent Inc.
  • Promega Corp.
  • Danaher Corp.
  • QIAGEN
  • Novogene Corporation
  • Oxford Nanopore Technologies
Product Code: SMRC24783

According to Stratistics MRC, the Global Gene Expression Analysis Market is accounted for $6.7 billion in 2026 and is expected to reach $15.1 billion by 2034 growing at a CAGR of 10.8% during the forecast period. Gene expression analysis refers to the study of the way genes are transcribed into RNA and translated into proteins, or the functional products they encode. It involves the measurement of the activity of genes in a particular cell, tissue, or organism under specific conditions. The analysis provides insights into wh Gene expression analysis for understanding the molecular mechanisms underlying various biological processes, including development, differentiation, response to stimuli, and diseases. By examining the patterns of gene expression, researchers can identify key genes involved in specific pathways, determine how genes are regulated, and gain insights into the molecular basis of diseases.

According to a 2016 survey conducted by the Federation of Indian Chambers of Commerce & Industry (FICCI), India faces an acute shortage of nearly 80% of Doctorate and Post Doctorate Scientists, a 20% shortage of people with a Master's degree, and a production staff shortage of 18% in the biotechnology sector.

Market Dynamics:

Driver:

Growing adoption of personalized medicine

The market is witnessing a surge in the adoption of personalized medicine, with a growing emphasis on tailoring treatments based on individual genetic profiles. This trend is driven by advancements in genomic research and technology, allowing for more precise analysis of gene expression patterns. As healthcare providers increasingly recognize the value of personalized approaches, the market is expected to expand further, offering innovative solutions for tailored therapies and diagnostics.

Restraint:

Shortage of trained professionals

The demand for skilled experts in interpreting and analyzing gene expression data far exceeds the current workforce supply. This shortage poses a significant challenge to harnessing the full potential of genomics in understanding diseases and developing targeted therapies. Addressing this gap through education and training initiatives is crucial to propel the field forward and unlock the transformative capabilities of gene expression analysis in healthcare and life sciences. The market faces a critical shortage of trained professionals, hindering advancements in genomic research and diagnostics.

Opportunity:

Rapid technological advancement

Innovations in high-throughput sequencing, single-cell analysis, and bioinformatics have propelled gene expression analysis to unprecedented levels of accuracy and efficiency. The continuous evolution of gene expression analysis technologies holds immense promise for advancing precision medicine and transforming our understanding of genetic regulation. The market has witnessed rapid technological advancement, revolutionizing the understanding of cellular function.

Threat:

High cost of the instruments

The sophisticated technology and specialized equipment required for gene expression analysis contribute to the elevated prices. This financial barrier may limit smaller laboratories or research facilities from fully engaging in comprehensive gene expression studies, potentially impacting the inclusivity and progress of scientific advancements in this field. Addressing cost concerns is crucial for fostering broader participation and innovation in gene expression analysis research. High cost of instruments is the factor hindering the growth of the market.

Covid-19 Impact:

The COVID-19 pandemic has significantly impacted the market. Increased focus on understanding the virus's molecular mechanisms has driven demand for gene expression analysis tools. However, disruptions in supply chains, laboratory closures, and reduced funding for research have posed challenges. The market has witnessed both surges and declines, with shifts in priorities towards infectious disease research. Adapting to remote work and digital solutions has become crucial for companies in this sector to navigate the uncertainties and maintain momentum.

The polymerase chain reaction (PCR) segment is expected to be the largest during the forecast period

The polymerase chain reaction (PCR) segment is expected to be the largest during the forecast period. This enables amplification of specific DNA sequences, facilitating gene expression analysis with high sensitivity and precision. Increasing demand for personalized medicine and advancements in genomics contribute to market expansion. Key players are investing in innovative PCR technologies, enhancing product portfolios. The market is poised for continuous growth, propelled by the expanding applications of PCR in diagnostics, therapeutics, and research endeavors.

The drug discovery & development segment is expected to have the highest CAGR during the forecast period

The drug discovery & development segment is expected to have the highest CAGR during the forecast period. Leveraging cutting-edge technologies, researchers analyze gene expression patterns to identify potential drug targets and biomarkers. This sophisticated approach enables a deeper understanding of disease mechanisms, aiding in the development of innovative therapeutics. With continuous advancements in genomics and bioinformatics, the market remains integral to shaping the future of precision medicine and personalized treatment strategies.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. The region showcases a strong demand for gene expression profiling tools, including microarrays and next-generation sequencing platforms. Key factors contributing to market growth include increasing research activities in genomics, rising prevalence of chronic diseases, and a supportive regulatory environment. Collaborations between research institutions and industry players further propel innovation in gene expression analysis, ensuring a flourishing market landscape.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period owing to the collaborations between academic institutions and biotechnology companies. . Key players in the region are actively developing innovative solutions for gene expression analysis, contributing to a dynamic and competitive landscape. The market's upward trajectory is expected to continue as the region becomes a prominent hub for genomics and molecular biology research.

Key players in the market

Some of the key players in Gene Expression Analysis market include Agilent Technologies, GE Healthcare, Illumina, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd., Luminex Corp., Quest Diagnostics, Inc., PerkinElmer, Inc., Takara Bio, Inc., Catalent Inc., Promega Corp., Danaher Corp., QIAGEN, Novogene Corporation and Oxford Nanopore Technologies.

Key Developments:

In August 2023, The MinION MK1C, a new sequencer designed to be more reasonably priced and available to researchers, has been launched, according to an announcement from Oxford Nanopore Technologies. Gene expression analysis and RNA and DNA sequencing can both be done using the MinION MK1C.

In January 2023, The bioinformatics division of QIAGEN, QIAGEN Digital Insights (QDI), has just launched the QIAGEN CLC Genomics Workbench Premium, which eliminates the data-analysis bottleneck of next-generation sequencing.

Products Covered:

  • DNA Chips
  • Kits & Reagents
  • Services
  • Other Products

Technologies Covered:

  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarrays
  • Other Technologies

Applications Covered:

  • Biotech & Microbiology
  • Clinical Diagnostics
  • Drug Discovery & Development
  • Other Applications

End Users Covered:

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gene Expression Analysis Market, By Product

  • 5.1 Introduction
  • 5.2 DNA Chips
  • 5.3 Kits & Reagents
  • 5.4 Services
  • 5.5 Other Products

6 Global Gene Expression Analysis Market, By Technology

  • 6.1 Introduction
  • 6.2 Next Generation Sequencing (NGS)
  • 6.3 Polymerase Chain Reaction (PCR)
  • 6.4 Microarrays
  • 6.5 Other Technologies

7 Global Gene Expression Analysis Market, By Application

  • 7.1 Introduction
  • 7.2 Biotech & Microbiology
  • 7.3 Clinical Diagnostics
  • 7.4 Drug Discovery & Development
  • 7.5 Other Applications

8 Global Gene Expression Analysis Market, By End User

  • 8.1 Introduction
  • 8.2 Academic and Research Institutes
  • 8.3 Pharmaceutical and Biotechnology Companies
  • 8.4 Other End Users

9 Global Gene Expression Analysis Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Agilent Technologies
  • 11.2 GE Healthcare
  • 11.3 Illumina, Inc.
  • 11.4 Thermo Fisher Scientific, Inc.
  • 11.5 Bio-Rad Laboratories
  • 11.6 F. Hoffmann-La Roche Ltd.
  • 11.7 Luminex Corp.
  • 11.8 Quest Diagnostics, Inc.
  • 11.9 PerkinElmer, Inc.
  • 11.10 Takara Bio, Inc.
  • 11.11 Catalent Inc.
  • 11.12 Promega Corp.
  • 11.13 Danaher Corp.
  • 11.14 QIAGEN
  • 11.15 Novogene Corporation
  • 11.16 Oxford Nanopore Technologies

List of Tables

  • Table 1 Global Gene Expression Analysis Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Gene Expression Analysis Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Gene Expression Analysis Market Outlook, By DNA Chips (2023-2034) ($MN)
  • Table 4 Global Gene Expression Analysis Market Outlook, By Kits & Reagents (2023-2034) ($MN)
  • Table 5 Global Gene Expression Analysis Market Outlook, By Services (2023-2034) ($MN)
  • Table 6 Global Gene Expression Analysis Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 7 Global Gene Expression Analysis Market Outlook, By Technology (2023-2034) ($MN)
  • Table 8 Global Gene Expression Analysis Market Outlook, By Next Generation Sequencing (NGS) (2023-2034) ($MN)
  • Table 9 Global Gene Expression Analysis Market Outlook, By Polymerase Chain Reaction (PCR) (2023-2034) ($MN)
  • Table 10 Global Gene Expression Analysis Market Outlook, By Microarrays (2023-2034) ($MN)
  • Table 11 Global Gene Expression Analysis Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 12 Global Gene Expression Analysis Market Outlook, By Application (2023-2034) ($MN)
  • Table 13 Global Gene Expression Analysis Market Outlook, By Biotech & Microbiology (2023-2034) ($MN)
  • Table 14 Global Gene Expression Analysis Market Outlook, By Clinical Diagnostics (2023-2034) ($MN)
  • Table 15 Global Gene Expression Analysis Market Outlook, By Drug Discovery & Development (2023-2034) ($MN)
  • Table 16 Global Gene Expression Analysis Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 17 Global Gene Expression Analysis Market Outlook, By End User (2023-2034) ($MN)
  • Table 18 Global Gene Expression Analysis Market Outlook, By Academic and Research Institutes (2023-2034) ($MN)
  • Table 19 Global Gene Expression Analysis Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
  • Table 20 Global Gene Expression Analysis Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 21 North America Gene Expression Analysis Market Outlook, By Country (2023-2034) ($MN)
  • Table 22 North America Gene Expression Analysis Market Outlook, By Product (2023-2034) ($MN)
  • Table 23 North America Gene Expression Analysis Market Outlook, By DNA Chips (2023-2034) ($MN)
  • Table 24 North America Gene Expression Analysis Market Outlook, By Kits & Reagents (2023-2034) ($MN)
  • Table 25 North America Gene Expression Analysis Market Outlook, By Services (2023-2034) ($MN)
  • Table 26 North America Gene Expression Analysis Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 27 North America Gene Expression Analysis Market Outlook, By Technology (2023-2034) ($MN)
  • Table 28 North America Gene Expression Analysis Market Outlook, By Next Generation Sequencing (NGS) (2023-2034) ($MN)
  • Table 29 North America Gene Expression Analysis Market Outlook, By Polymerase Chain Reaction (PCR) (2023-2034) ($MN)
  • Table 30 North America Gene Expression Analysis Market Outlook, By Microarrays (2023-2034) ($MN)
  • Table 31 North America Gene Expression Analysis Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 32 North America Gene Expression Analysis Market Outlook, By Application (2023-2034) ($MN)
  • Table 33 North America Gene Expression Analysis Market Outlook, By Biotech & Microbiology (2023-2034) ($MN)
  • Table 34 North America Gene Expression Analysis Market Outlook, By Clinical Diagnostics (2023-2034) ($MN)
  • Table 35 North America Gene Expression Analysis Market Outlook, By Drug Discovery & Development (2023-2034) ($MN)
  • Table 36 North America Gene Expression Analysis Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 37 North America Gene Expression Analysis Market Outlook, By End User (2023-2034) ($MN)
  • Table 38 North America Gene Expression Analysis Market Outlook, By Academic and Research Institutes (2023-2034) ($MN)
  • Table 39 North America Gene Expression Analysis Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
  • Table 40 North America Gene Expression Analysis Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 41 Europe Gene Expression Analysis Market Outlook, By Country (2023-2034) ($MN)
  • Table 42 Europe Gene Expression Analysis Market Outlook, By Product (2023-2034) ($MN)
  • Table 43 Europe Gene Expression Analysis Market Outlook, By DNA Chips (2023-2034) ($MN)
  • Table 44 Europe Gene Expression Analysis Market Outlook, By Kits & Reagents (2023-2034) ($MN)
  • Table 45 Europe Gene Expression Analysis Market Outlook, By Services (2023-2034) ($MN)
  • Table 46 Europe Gene Expression Analysis Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 47 Europe Gene Expression Analysis Market Outlook, By Technology (2023-2034) ($MN)
  • Table 48 Europe Gene Expression Analysis Market Outlook, By Next Generation Sequencing (NGS) (2023-2034) ($MN)
  • Table 49 Europe Gene Expression Analysis Market Outlook, By Polymerase Chain Reaction (PCR) (2023-2034) ($MN)
  • Table 50 Europe Gene Expression Analysis Market Outlook, By Microarrays (2023-2034) ($MN)
  • Table 51 Europe Gene Expression Analysis Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 52 Europe Gene Expression Analysis Market Outlook, By Application (2023-2034) ($MN)
  • Table 53 Europe Gene Expression Analysis Market Outlook, By Biotech & Microbiology (2023-2034) ($MN)
  • Table 54 Europe Gene Expression Analysis Market Outlook, By Clinical Diagnostics (2023-2034) ($MN)
  • Table 55 Europe Gene Expression Analysis Market Outlook, By Drug Discovery & Development (2023-2034) ($MN)
  • Table 56 Europe Gene Expression Analysis Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 57 Europe Gene Expression Analysis Market Outlook, By End User (2023-2034) ($MN)
  • Table 58 Europe Gene Expression Analysis Market Outlook, By Academic and Research Institutes (2023-2034) ($MN)
  • Table 59 Europe Gene Expression Analysis Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
  • Table 60 Europe Gene Expression Analysis Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 61 Asia Pacific Gene Expression Analysis Market Outlook, By Country (2023-2034) ($MN)
  • Table 62 Asia Pacific Gene Expression Analysis Market Outlook, By Product (2023-2034) ($MN)
  • Table 63 Asia Pacific Gene Expression Analysis Market Outlook, By DNA Chips (2023-2034) ($MN)
  • Table 64 Asia Pacific Gene Expression Analysis Market Outlook, By Kits & Reagents (2023-2034) ($MN)
  • Table 65 Asia Pacific Gene Expression Analysis Market Outlook, By Services (2023-2034) ($MN)
  • Table 66 Asia Pacific Gene Expression Analysis Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 67 Asia Pacific Gene Expression Analysis Market Outlook, By Technology (2023-2034) ($MN)
  • Table 68 Asia Pacific Gene Expression Analysis Market Outlook, By Next Generation Sequencing (NGS) (2023-2034) ($MN)
  • Table 69 Asia Pacific Gene Expression Analysis Market Outlook, By Polymerase Chain Reaction (PCR) (2023-2034) ($MN)
  • Table 70 Asia Pacific Gene Expression Analysis Market Outlook, By Microarrays (2023-2034) ($MN)
  • Table 71 Asia Pacific Gene Expression Analysis Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 72 Asia Pacific Gene Expression Analysis Market Outlook, By Application (2023-2034) ($MN)
  • Table 73 Asia Pacific Gene Expression Analysis Market Outlook, By Biotech & Microbiology (2023-2034) ($MN)
  • Table 74 Asia Pacific Gene Expression Analysis Market Outlook, By Clinical Diagnostics (2023-2034) ($MN)
  • Table 75 Asia Pacific Gene Expression Analysis Market Outlook, By Drug Discovery & Development (2023-2034) ($MN)
  • Table 76 Asia Pacific Gene Expression Analysis Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 77 Asia Pacific Gene Expression Analysis Market Outlook, By End User (2023-2034) ($MN)
  • Table 78 Asia Pacific Gene Expression Analysis Market Outlook, By Academic and Research Institutes (2023-2034) ($MN)
  • Table 79 Asia Pacific Gene Expression Analysis Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
  • Table 80 Asia Pacific Gene Expression Analysis Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 81 South America Gene Expression Analysis Market Outlook, By Country (2023-2034) ($MN)
  • Table 82 South America Gene Expression Analysis Market Outlook, By Product (2023-2034) ($MN)
  • Table 83 South America Gene Expression Analysis Market Outlook, By DNA Chips (2023-2034) ($MN)
  • Table 84 South America Gene Expression Analysis Market Outlook, By Kits & Reagents (2023-2034) ($MN)
  • Table 85 South America Gene Expression Analysis Market Outlook, By Services (2023-2034) ($MN)
  • Table 86 South America Gene Expression Analysis Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 87 South America Gene Expression Analysis Market Outlook, By Technology (2023-2034) ($MN)
  • Table 88 South America Gene Expression Analysis Market Outlook, By Next Generation Sequencing (NGS) (2023-2034) ($MN)
  • Table 89 South America Gene Expression Analysis Market Outlook, By Polymerase Chain Reaction (PCR) (2023-2034) ($MN)
  • Table 90 South America Gene Expression Analysis Market Outlook, By Microarrays (2023-2034) ($MN)
  • Table 91 South America Gene Expression Analysis Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 92 South America Gene Expression Analysis Market Outlook, By Application (2023-2034) ($MN)
  • Table 93 South America Gene Expression Analysis Market Outlook, By Biotech & Microbiology (2023-2034) ($MN)
  • Table 94 South America Gene Expression Analysis Market Outlook, By Clinical Diagnostics (2023-2034) ($MN)
  • Table 95 South America Gene Expression Analysis Market Outlook, By Drug Discovery & Development (2023-2034) ($MN)
  • Table 96 South America Gene Expression Analysis Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 97 South America Gene Expression Analysis Market Outlook, By End User (2023-2034) ($MN)
  • Table 98 South America Gene Expression Analysis Market Outlook, By Academic and Research Institutes (2023-2034) ($MN)
  • Table 99 South America Gene Expression Analysis Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
  • Table 100 South America Gene Expression Analysis Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 101 Middle East & Africa Gene Expression Analysis Market Outlook, By Country (2023-2034) ($MN)
  • Table 102 Middle East & Africa Gene Expression Analysis Market Outlook, By Product (2023-2034) ($MN)
  • Table 103 Middle East & Africa Gene Expression Analysis Market Outlook, By DNA Chips (2023-2034) ($MN)
  • Table 104 Middle East & Africa Gene Expression Analysis Market Outlook, By Kits & Reagents (2023-2034) ($MN)
  • Table 105 Middle East & Africa Gene Expression Analysis Market Outlook, By Services (2023-2034) ($MN)
  • Table 106 Middle East & Africa Gene Expression Analysis Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 107 Middle East & Africa Gene Expression Analysis Market Outlook, By Technology (2023-2034) ($MN)
  • Table 108 Middle East & Africa Gene Expression Analysis Market Outlook, By Next Generation Sequencing (NGS) (2023-2034) ($MN)
  • Table 109 Middle East & Africa Gene Expression Analysis Market Outlook, By Polymerase Chain Reaction (PCR) (2023-2034) ($MN)
  • Table 110 Middle East & Africa Gene Expression Analysis Market Outlook, By Microarrays (2023-2034) ($MN)
  • Table 111 Middle East & Africa Gene Expression Analysis Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 112 Middle East & Africa Gene Expression Analysis Market Outlook, By Application (2023-2034) ($MN)
  • Table 113 Middle East & Africa Gene Expression Analysis Market Outlook, By Biotech & Microbiology (2023-2034) ($MN)
  • Table 114 Middle East & Africa Gene Expression Analysis Market Outlook, By Clinical Diagnostics (2023-2034) ($MN)
  • Table 115 Middle East & Africa Gene Expression Analysis Market Outlook, By Drug Discovery & Development (2023-2034) ($MN)
  • Table 116 Middle East & Africa Gene Expression Analysis Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 117 Middle East & Africa Gene Expression Analysis Market Outlook, By End User (2023-2034) ($MN)
  • Table 118 Middle East & Africa Gene Expression Analysis Market Outlook, By Academic and Research Institutes (2023-2034) ($MN)
  • Table 119 Middle East & Africa Gene Expression Analysis Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
  • Table 120 Middle East & Africa Gene Expression Analysis Market Outlook, By Other End Users (2023-2034) ($MN)